These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7749861)

  • 1. Synthetic analogues of the antithrombin III-binding pentasaccharide sequence of heparin. Prediction of in vivo residence times.
    van Amsterdam RG; Vogel GM; Visser A; Kop WJ; Buiting MT; Meuleman DG
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):495-503. PubMed ID: 7749861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of three synthetic AT-binding pentasaccharides in various animal species-extrapolation to humans.
    Hérault JP; Donat F; Bàrzu T; Crépon B; Bernat A; Lormeau JC; Herbert JM
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):161-7. PubMed ID: 9167016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.
    Westerduin P; van Boeckel CA; Basten JE; Broekhoven MA; Lucas H; Rood A; van der Heijden H; van Amsterdam RG; van Dinther TG; Meuleman DG
    Bioorg Med Chem; 1994 Nov; 2(11):1267-80. PubMed ID: 7757423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
    Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
    Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation.
    Kridel SJ; Knauer DJ
    J Biol Chem; 1997 Mar; 272(12):7656-60. PubMed ID: 9065421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216.
    Carrie D; Caranobe C; Saivin S; Houin G; Petitou M; Lormeau JC; Van Boeckel C; Meuleman D; Boneu B
    Blood; 1994 Oct; 84(8):2571-7. PubMed ID: 7919374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the anti-factor Xa activity of the synthetic pentasaccharide SR 90107A/ORG 31540 and of two structural analogues.
    Lormeau JC; Herault JP; Gaich C; Barzu T; van Dinther TG; Visser A; Herbert JM
    Thromb Res; 1997 Jan; 85(1):67-75. PubMed ID: 8983127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
    Lormeau JC; Herault JP; Herbert JM
    Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implications.
    Daud AN; Ahsan A; Iqbal O; Walenga JM; Silver PJ; Ahmad S; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):58-64. PubMed ID: 11190907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III.
    Kridel SJ; Chan WW; Knauer DJ
    J Biol Chem; 1996 Aug; 271(34):20935-41. PubMed ID: 8702852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of ATIII-binding pentasaccharides to extend the half-life of proteins: long-acting insulin.
    de Kort M; Gianotten B; Wisse JA; Bos ES; Eppink MH; Mattaar E; Vogel GM; Dokter WH; Honing M; Vonsovic S; Smit MJ; Wijkmans JC; van Boeckel CA
    ChemMedChem; 2008 Aug; 3(8):1189-93. PubMed ID: 18433074
    [No Abstract]   [Full Text] [Related]  

  • 20. Examination, by 1H-n.m.r. spectroscopy, of the binding of a synthetic, high-affinity heparin pentasaccharide to human antithrombin III.
    Gettins P; Choay J
    Carbohydr Res; 1989 Jan; 185(1):69-76. PubMed ID: 2713873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.